Forging the future of cell therapy: Bayer and BlueRock’s unique journey

In this episode of The Top Line, Fierce Biotech’s Chris Hayden sat down with Dr. Juergen Eckhardt of Bayer and Dr. Seth Ettenberg of Ä¢¹½¶ÌÊÓÆµ to discuss an innovative partnership that’s reshaping how big pharma teams up with biotech startups.

Related News

Podcasts

Eye on the Cure Podcast

June 5, 2025
Podcasts

Cell & Gene The Podcast: Inside Ä¢¹½¶ÌÊÓÆµ’ Parkinson’s Disease Trial

April 25, 2024
Podcasts

Headlines of the Future Podcast: The Future of Cell and Gene Therapies

November 22, 2023
Podcasts

Eye on the Cure Podcast

June 5, 2025
Podcasts

Cell & Gene The Podcast: Inside Ä¢¹½¶ÌÊÓÆµ’ Parkinson’s Disease Trial

April 25, 2024
Podcasts

Headlines of the Future Podcast: The Future of Cell and Gene Therapies

November 22, 2023